Drug Shortages Proposal From Sen. Hatch Offers 7-Year Economic Incentives
This article was originally published in The Gold Sheet
Executive Summary
The Utah Republican’s draft bill would encourage industry to increase its capacity to manufacture sterile injectable drug products by providing higher reimbursement rates and exclusivity incentives. House Republicans continue to pursue economic options, but time and jurisdictional factors could work against such measures to address shortages.